Cutaneous Mast Cell Receptors

Dermatologic Clinics

Volumn 25, Issue 4, 2007, Pages 563-575

  Hide, Michihiro ^a   Yanase, Yuhki ^a   Greaves, Malcolm W ^b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD33 ANTIGEN; CD45 ANTIGEN; CD63 ANTIGEN; COMPLEMENT COMPONENT C5A RECEPTOR; FC RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTAMINE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LEUKOTRIENE B4 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; NEUROKININ 1 RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 2; STEM CELL FACTOR; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR;

ATOPIC DERMATITIS; CYTOKINE PRODUCTION; HUMAN; MAST CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PRURITUS; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; URTICARIA;

ANIMALS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAST CELLS; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; SKIN PHYSIOLOGY;

EID: 34648854424     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2007.06.013     Document Type: Review

References (113)

1. Kitamura Y., and Ito A. Mast cell-committed progenitors. Proc Natl Acad Sci U S A 102 32 (2005) 11129-11130
2. Kitamura Y., Shimada M., Hatanaka K., et al. Development of mast cells from grafted bone marrow cells in irradiated mice. Nature 268 5619 (1977) 442-443
3. Li L., and Krilis S.A. Mast-cell growth and differentiation. Allergy 54 4 (1999) 306-312
4. Irani A.A., Schechter N.M., Craig S.S., et al. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci U S A 83 12 (1986) 4464-4468
5. TC cells. J Immunol 147 1 (1991) 247-253
6. TC type of human mast cells. J Immunol 145 8 (1990) 2652-2661
7. Kambe N., Kambe M., Kochan J.P., et al. Human skin-derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes. Blood 97 7 (2001) 2045-2052
8. Füreder W., Agis H., Willheim M., et al. Differential expression of complement receptors on human basophils and mast cells. J Immunol 155 6 (1995) 3152-3160
9. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., et al. Mast cell as tunable effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23 (2005) 749-786
10. Bradding P., and Holgate S.T. Immunopathology and human mast cell cytokines. Crit Rev Oncol Hematol 31 2 (1999) 119-133
11. Kobayashi H., Ishizuka T., and Okayama Y. Human mast cells and basophils as sources of cytokines. Clin Exp Allergy 30 9 (2000) 1205-1212
12. Marshall J.S. Mast-cell response to pathogens. Nat Rev Immunol 4 10 (2004) 787-799
13. Puxeddu I., Piliponsky A.M., Bachelet I., et al. Mast cells in allergy and beyond. Int J Biochem Cell Biol 35 12 (2003) 1601-1607
14. Benoist C., and Mathis D. Mast cells in autoimmune disease. Nature 420 6917 (2002) 875-878
15. Arck P.C., Slominski A., Theoharides T.C., et al. Neuroimmunology of stress: skin takes center stage. J Invest Dermatol 126 8 (2006) 1697-1704
16. Blank U., and Rivera J. The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol 25 5 (2004) 266-273
17. Rivera J., and Gilfillan A.M. Molecular regulation of mast cell activation. J Allergy Clin Immunol 117 6 (2006) 1214-1225
18. Siraganian R.P. Mast cell signal transduction from the high-affinity IgE receptor. Curr Opin Immunol 15 6 (2003) 639-646
19. Patterson R.L., van Rossum D.B., Nikolaidis N., et al. Phospholipase C-γ: diverse roles in receptor-mediated calcium signaling. Trends Biochem Sci 30 12 (2005) 688-697
20. Spitaler M., and Cantrell D.A. Protein kinase C and beyond. Nat Immunol 5 8 (2004) 785-790
21. Jabril-Cuenod B., Zhang C., Scharenberg A.M., et al. Syk-dependent phosphorylation of Shc. J Biol Chem 271 27 (1996) 16268-16272
22. Teramoto H., Salem P., Robbins K.C., et al. Tyrosine phosphorylation of the vav proto-oncogene product links FcεRI to the Rac-JNK pathway. J Biol Chem 272 16 (1997) 10751-10755
23. Zhang C., Baumgartner R.A., Yamada K., et al. Mitogen-activated protein (MAP) kinase regulates production of tumor necrosis factor-α and release of arachidonic acid in mast cells. J Biol Chem 272 20 (1997) 13397-13402
24. Hundley T.R., Gilfillan A.M., Tkaczyk C., et al. Kit and FcεRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells. Blood 104 8 (2004) 2410-2417
25. Veillette A., Latour S., and Davidson D. Negative regulation of immunoreceptor signaling. Annu Rev Immunol 20 (2002) 669-707
26. Huber M., Helgason C.D., Damen J.E., et al. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proc Natl Acad Sci U S A 95 19 (1998) 11330-11335
27. Maeyama K., Hohman R.J., Ali H., et al. Assessment of IgE-receptor function through measurement of hydrolysis of membrane inositol phospholipids: new insights on the phenomena of biphasic antigen concentration-response curves and desensitization. J Immunol 140 11 (1988) 3919-3927
28. Pandy V., Mihara S., Fensome-Green A., et al. Monomeric IgE stimulates NFAT translocation into the nucleus, a rise in cytosol Ca2+, degranulation, and membrane ruffling in the cultured rat basophilic leukemia-2H3 mast cell line. J Immunol 172 7 (2004) 4048-4058
29. Kawakami T., and Kitaura J. Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance. J Immunol 175 7 (2005) 4167-4173
30. Hide M., Francis D.M., Grattan C.E., et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 328 22 (1993) 1599-1604
31. Fiebiger E., Maurer D., Holub H., et al. Serum IgG autoantibodies directed against the alpha chain of FcεRI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients?. J Clin Invest 96 6 (1995) 2606-2612
32. Ferrer M., Nakazawa K., and Kaplan A.P. Complement dependence of histamine release in chronic urticaria. J Allergy Clin Immunol 104 1 (1999) 169-172
33. Gilfillan A.M., and Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat Rev Immunol 6 3 (2006) 218-230
34. Ronnstrand L. Signal transduction via the stem cell factor receptor/c-Kit. Cell Mol Life Sci 61 19-20 (2004) 2535-2548
35. Iwaki S., Tkaczyk C., Satterthwaite A.B., et al. Btk plays a crucial role in the amplification of FcεRI-mediated mast cell activation by kit. J Biol Chem 280 48 (2005) 40261-40270
36. Longley Jr. B.J., Morganroth G.S., Tyrrell L., et al. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med 328 18 (1993) 1302-1307
37. Nagata H., Okada T., Worobec A.S., et al. c-kit mutation in a population of patients with mastocytosis. Int Arch Allergy Immunol 113 1-3 (1997) 184-186
38. Nelms K., Keegan A.D., Zamorano J., et al. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 17 (1999) 701-738
39. Nabeshima Y., Hiragun T., Morita E., et al. IL-4 modulates the histamine content of mast cells in a mast cell/fibroblast co-culture through a Stat6 signaling pathway in fibroblasts. FEBS Lett 579 29 (2005) 6653-6658
40. Lorentz A., and Bischoff S.C. Regulation of human intestinal mast cells by stem cell factor and IL-4. Immunol Rev 179 (2001) 57-60
41. Lorentz A., Wilke M., Sellge G., et al. IL-4-induced priming of human intestinal mast cells for enhanced survival and Th2 cytokine generation is reversible and associated with increased activity of ERK1/2 and c-Fos. J Immunol 174 11 (2005) 6751-6756
42. Hershey G.K., Friedrich M.F., Esswein L.A., et al. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med 337 24 (1997) 1720-1725
43. Shirakawa I., Deichmann K.A., Izuhara I., et al. Atopy and asthma: genetic variants of IL-4 and IL-13 signalling. Immunol Today 21 2 (2000) 60-64
44. Dupre D., Audrezet M.P., and Ferec C. Atopy and a mutation in the interleukin-4 receptor gene. N Engl J Med 343 1 (2000) 69-70
45. Franjkovic I., Gessner A., Konig I., et al. Effects of common atopy-associated amino acid substitutions in the IL-4 receptor alpha chain on IL-4 induced phenotypes. Immunogenetics 56 11 (2005) 808-817
46. Guhl S., Lee H.H., Babina M., et al. Evidence for a restricted rather than generalized stimulatory response of skin-derived human mast cells to substance P. J Neuroimmunol 163 1-2 (2005) 92-101
47. Gerard N.P., Garraway L.A., Eddy Jr. R.L., et al. Human substance P receptor (NK-1): organization of the gene, chromosome localization, and functional expression of cDNA clones. Biochemistry 30 44 (1991) 10640-10646
48. Heaney L.G., Cross L.J., Stanford C.F., et al. Substance P induces histamine release from human pulmonary mast cells. Clin Exp Allergy 25 2 (1995) 179-186
49. Bischoff S.C., Schwengberg S., Lorentz A., et al. Substance P and other neuropeptides do not induce mediator release in isolated human intestinal mast cells. Neurogastroenterol Motil 16 2 (2004) 185-193
50. Okabe T., Hide M., Koro O., et al. Substance P induces tumor necrosis factor-α release from human skin via mitogen-activated protein kinase. Eur J Pharmacol 398 2 (2000) 309-315
51. Okabe T., Hide M., Koro O., et al. The release of leukotriene B4 from human skin in response to substance P: evidence for the functional heterogeneity of human skin mast cells among individuals. Clin Exp Immunol 124 1 (2001) 150-156
52. Okabe T., Hide M., Hiragun T., et al. Bone marrow derived mast cell acquire responsiveness to substance P with Ca(2+) signals and release of leukotriene B(4) via mitogen-activated protein kinase. J Neuroimmunol 181 1-2 (2006) 1-12
53. Steinhoff M., Vergnolle N., Young S.H., et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 6 2 (2000) 151-158
54. Lippert U., Moller A., Welker P., et al. Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists. Exp Dermatol 9 2 (2000) 118-124 [Erratum in: Exp Dermatol 2002;11(4):386]
55. Hofstra C.L., Desai P.J., Thurmond R.L., et al. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther 305 3 (2003) 1212-1221
56. Bell J.K., McQueen D.S., and Rees J.L. Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in Balb C mice. Br J Pharmacol 142 2 (2004) 374-380
57. Stempelj M., and Ferjan I. Signaling pathway in nerve growth factor induced histamine release from rat mast cells. Inflamm Res 54 8 (2005) 344-349
58. Huang E.J., and Reichardt L.F. Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72 (2003) 609-642
59. Groneberg D.A., Serowka F., Peckenschneider N., et al. Gene expression and regulation of nerve growth factor in atopic dermatitis mast cells and the human mast cell line-1. J Neuroimmunol 161 1-2 (2005) 87-92
60. Grewe M., Vogelsang K., Ruzicka T., et al. Neurotrophin-4 production by human epidermal keratinocytes: increased expression in atopic dermatitis. J Invest Dermatol 114 6 (2000) 1108-1112
61. Moormann C., Artuc M., Pohl E., et al. Functional characterization and expression analysis of the proteinase-activated receptor-2 in human cutaneous mast cells. J Invest Dermatol 126 4 (2006) 746-755
62. Guo R.F., and Ward P.A. Role of C5a in inflammatory responses. Annu Rev Immunol 23 (2005) 821-852
63. el-Lati S.G., Dahinden C.A., and Church M.K. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells. J Invest Dermatol 102 5 (1994) 803-806
64. Hartmann K., Henz B.M., Kruger-Krasagakes S., et al. C3a and C5a stimulate chemotaxis of human mast cells. Blood 89 8 (1997) 2863-2870
65. Oskeritzian C.A., Zhao W., Min H.K., et al. Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell. J Allergy Clin Immunol 115 6 (2005) 1162-1168
66. Wojta J., Kaun C., Zorn G., et al. C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils. Blood 100 2 (2002) 517-523
67. Kikuchi Y., and Kaplan A.P. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol 109 1 (2002) 114-118
68. Akira S. Toll-like receptor signaling. J Biol Chem 278 40 (2003) 38105-38108
69. Kulka M., and Metcalfe D.D. TLR3 activation inhibits human mast cell attachment to fibronectin and vitronectin. Mol Immunol 43 10 (2006) 1579-1586
70. McCurdy J.D., Olynych T.J., Maher L.H., et al. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol 170 4 (2003) 1625-1629
71. Kulka M., Alexopoulou L., Flavell R.A., et al. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol 114 1 (2004) 174-182
72. Varadaradjalou S., Feger F., Thieblemont N., et al. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur J Immunol 33 4 (2003) 899-906
73. Supajatura V., Ushio H., Nakao A., et al. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest 109 10 (2002) 1351-1359
74. Bruhns P., Fremont S., and Daeron M. Regulation of allergy by Fc receptors. Curr Opin Immunol 17 6 (2005) 662-669
75. Stefanescu R.N., Olferiev M., Liu Y., et al. Inhibitory Fc gamma receptors: from gene to disease. J Clin Immunol 24 4 (2004) 315-326
76. Hermes B., Zuberbier T., Haas N., et al. Decreased cutaneous of stem cell factor and of the p75NGF receptor in urficaria. Br J Dermatol 148 3 (2003) 411-417
77. Rauh M.J., Kalesnikoff J., Hughes M., et al. Role of Src homology 2-containing-inositol 5'-phosphatase (SHIP) in mast cells and macrophages. Biochem Soc Trans 31 Pt 1 (2003) 286-291
78. Tam S.W., Demissie S., Thomas D., et al. A bispecific antibody against human IgE and human FcγRII that inhibits antigen-induced histamine release by human mast cells and basophils. Allergy 59 7 (2004) 772-780
79. Zhao W., Kepley C.L., Morel P.A., et al. FcγRIIa, not FcγRIIb, is constitutively and functionally expressed on skin-derived human mast cells. J Immunol 177 1 (2006) 694-701
80. Li L., and Yao Z. Mast cell and immune inhibitory receptors. Cell Mol Immunol 1 6 (2004) 408-415
81. Crocker P.R., and Varki A. Siglecs, sialic acids and innate immunity. Trends Immunol 22 6 (2001) 337-342
82. Ghannadan M., Baghestanian M., Wimazal F., et al. Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies. J Invest Dermatol 111 4 (1998) 689-695
83. Siraganian R.P., Zhang J., Suzuki K., et al. Protein tyrosine kinase Syk in mast cell signaling. Mol Immunol 38 16-18 (2002) 1229-1233
84. Irie-Sasaki J., Sasaki T., Matsumoto W., et al. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature 409 6818 (2001) 349-354
85. Radford K.J., Thorne R.F., and Hersey P. Regulation of tumor cell motility and migration by CD63 in a human melanoma cell line. J Immunol 158 7 (1997) 3353-3358
86. Grutzkau A., Smorodchenko A., Lippert U., et al. LAMP-1 and LAMP-2, but not LAMP-3, are reliable markers for activation-induced secretion of human mast cells. Cytometry A 61 1 (2004) 62-68
87. Kraft S., Fleming T., Billingsley J.M., et al. Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo. J Exp Med 201 3 (2005) 385-396
88. Escribano L., Orfao A., Diaz Agustin B., et al. Human bone marrow mast cells from indolent systemic mast cell disease constitutively express increased amounts of the CD63 protein on their surface. Cytometry 34 5 (1998) 223-228
89. Gyimesi E., Sipka S., Danko K., et al. Basophil CD63 expression assay on highly sensitized atopic donor leucocytes-a useful method in chronic autoimmune urticaria. Br J Dermatol 151 2 (2004) 388-396
90. Sancho D., Santis A.G., Alonso-Lebrero J.L., et al. Functional analysis of ligand-binding and signal transduction domains of CD69 and CD23 C-type lectin leukocyte receptors. J Immunol 165 7 (2000) 3868-3875
91. Testi R., D'Ambrosio D., De Maria R., et al. The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol Today 15 10 (1994) 479-483
92. Diaz-Agustin B., Escribano L., Bravo P., et al. The CD69 early activation molecule is overexpressed in human bone marrow mast cells from adults with indolent systemic mast cell disease. Br J Haematol 106 2 (1999) 400-405
93. Hauswirth A.W., Florian S., Schernthaner G.H., et al. Expression of cell surface antigens on mast cells: mast cell phenotyping. Methods Mol Biol 315 (2006) 77-90
94. Boumiza R., Monneret G., Forissier M.F., et al. Marked improvement of the basophil activation test by detecting CD203c instead of CD63. Clin Exp Allergy 33 2 (2003) 259-265
95. Yasnowsky K.M., Dreskin S.C., Efaw B., et al. Chronic urticaria sera increase basophil CD203c expression. J Allergy Clin Immunol 117 6 (2006) 1430-1434
96. Schernthaner G.H., Hauswirth A.W., Baghestanian M., et al. Detection of differentiation- and activation-linked cell surface antigens on cultured mast cell progenitors. Allergy 60 10 (2005) 1248-1255
97. Valent P., Schernthaner G.H., Sperr W.R., et al. Variable expression of activation-linked surface antigens on human mast cells in health and disease. Immunol Rev 179 (2001) 74-81
98. Babina M., Guhl S., Starke A., et al. Comparative cytokine profile of human skin mast cells from two compartments: strong resemblance with monocytes at baseline but induction of IL-5 by IL-4 priming. J Leukoc Biol 75 2 (2004) 244-252
99. Lippert U., Artuc M., Grutzkau A., et al. Human skin mast cells express H2 and H4, but not H3 receptors. J Invest Dermatol 123 1 (2004) 116-123
100. He S.H., Xie H., and Fu Y.L. Activation of human tonsil and skin mast cells by agonists of proteinase activated receptor-2. Acta Pharmacol Sin 26 5 (2005) 568-574
101. Ghannadan M., Hauswirth A.W., Schernthaner G.H., et al. Detection of novel CD antigens on the surface of human mast cells and basophils. Int Arch Allergy Immunol 127 4 (2002) 299-307
102. Ochi H., De Jesus N.H., Hsieh F.H., et al. IL-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production. Proc Natl Acad Sci U S A 97 19 (2000) 10509-10513
103. Tam S.Y., Tsai M., Yamaguchi M., et al. Expression of functional TrkA receptor tyrosine kinase in the HMC-1 human mast cell line and in human mast cells. Blood 90 5 (1997) 1807-1820
104. He S., Aslam A., Gaca M.D., et al. Inhibitors of tryptase as mast cell-stabilizing agents in the human airways: effects of tryptase and other agonists of proteinase-activated receptor 2 on histamine release. J Pharmacol Exp Ther 309 1 (2004) 119-126
105. Kitamura Y., and Hirotab S. Kit as a human oncogenic tyrosine kinase. Cell Mol Life Sci 61 23 (2004) 2924-2931
106. Monastyrskaya K., Hostettler A., Buergi S., et al. The NK1 receptor localizes to the plasma membrane microdomains, and its activation is dependent on lipid raft integrity. J Biol Chem 280 8 (2005) 7135-7146
107. Akdis C.A., and Simons F.E. Histamine receptors are hot in immunopharmacology. Eur J Pharmacol 533 1-3 (2006) 69-76
108. Steinhoff M., Buddenkotte J., Shpacovitch V., et al. Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev 26 1 (2005) 1-43
109. Auger G.A., Smith B.M., Pease J.E., et al. The use of membrane translocating peptides to identify sites of interaction between the C5a receptor and downstream effector proteins. Immunology 112 4 (2004) 590-596
110. Elsner J., Oppermann M., Czech W., et al. C3a activates the respiratory burst in human polymorphonuclear neutrophilic leukocytes via pertussis toxin-sensitive G-proteins. Blood 83 11 (1994) 3324-3331
111. Takeda K., and Akira S. TLR signaling pathways. Semin Immunol 16 1 (2004) 3-9
112. Huntington N.D., and Tarlinton D.M. CD45: direct and indirect government of immune regulation. Immunol Lett 94 3 (2004) 167-174
113. TC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem 37 10 (1989) 1509-1515